Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elza Muscelli

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Diabetes|July 10, 2013
Long-term effects of bariatric surgery on meal disposal and β-cell function in diabetic and nondiabetic patientsStefania Camastra, Elza Muscelli, Amalia Gastaldelli, et al.
Diabetologia|December 26, 2015
Metabolic consequences of acute and chronic empagliflozin administration in treatment-naive and metformin pretreated patients with type 2 diabetesElza Muscelli, Brenno Astiarraga, Elisabetta Barsotti, et al.
Hypertension (Dallas, Tex. : 1979)|January 4, 2008
Early hypertension is associated with reduced regional cardiac function, insulin resistance, epicardial, and visceral fatAnna Maria Sironi, Alessandro Pingitore, Sergio Ghione, et al.
Diabetologia|May 8, 2018
Effects of acute NEFA manipulation on incretin-induced insulin secretion in participants with and without type 2 diabetesBrenno Astiarraga, Valéria B Chueire, Aglécio L Souza, et al.
Arquivos Brasileiros De Endocrinologia E Metabologia|May 26, 2009
Overcoming metabolic syndrome in severe obesity: adiponectin as a marker of insulin sensitivity and HDL-cholesterol improvements after gastric bypassBruno Geloneze, Juliano Alves Pereira, José Carlos Pareja, et al.
Obesity Surgery|September 26, 2008
GLP-1 and adiponectin: effect of weight loss after dietary restriction and gastric bypass in morbidly obese patients with normal and abnormal glucose metabolismCamila Puzzi de Carvalho, Daniela Miguel Marin, Aglécio Luiz de Souza, et al.
Nutrition & Diabetes|June 13, 2021
Dapagliflozin increases the lean-to total mass ratio in type 2 diabetes mellitusVaneza Lira W Wolf, Ikaro Breder, Luiz Sérgio F de Carvalho, et al.
Therapeutic Advances in Chronic Disease|October 16, 2020
Rationale and design of the expanded combination of evolocumab plus empagliflozin in diabetes: EXCEED-BHS3 trialIkaro Breder, Jessica Cunha Breder, Isabella Bonilha, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Diabetes|July 10, 2013
Long-term effects of bariatric surgery on meal disposal and β-cell function in diabetic and nondiabetic patientsStefania Camastra, Elza Muscelli, Amalia Gastaldelli, et al.
Diabetologia|December 26, 2015
Metabolic consequences of acute and chronic empagliflozin administration in treatment-naive and metformin pretreated patients with type 2 diabetesElza Muscelli, Brenno Astiarraga, Elisabetta Barsotti, et al.
Hypertension (Dallas, Tex. : 1979)|January 4, 2008
Early hypertension is associated with reduced regional cardiac function, insulin resistance, epicardial, and visceral fatAnna Maria Sironi, Alessandro Pingitore, Sergio Ghione, et al.
Diabetologia|May 8, 2018
Effects of acute NEFA manipulation on incretin-induced insulin secretion in participants with and without type 2 diabetesBrenno Astiarraga, Valéria B Chueire, Aglécio L Souza, et al.
Arquivos Brasileiros De Endocrinologia E Metabologia|May 26, 2009
Overcoming metabolic syndrome in severe obesity: adiponectin as a marker of insulin sensitivity and HDL-cholesterol improvements after gastric bypassBruno Geloneze, Juliano Alves Pereira, José Carlos Pareja, et al.
Obesity Surgery|September 26, 2008
GLP-1 and adiponectin: effect of weight loss after dietary restriction and gastric bypass in morbidly obese patients with normal and abnormal glucose metabolismCamila Puzzi de Carvalho, Daniela Miguel Marin, Aglécio Luiz de Souza, et al.
Nutrition & Diabetes|June 13, 2021
Dapagliflozin increases the lean-to total mass ratio in type 2 diabetes mellitusVaneza Lira W Wolf, Ikaro Breder, Luiz Sérgio F de Carvalho, et al.
Therapeutic Advances in Chronic Disease|October 16, 2020
Rationale and design of the expanded combination of evolocumab plus empagliflozin in diabetes: EXCEED-BHS3 trialIkaro Breder, Jessica Cunha Breder, Isabella Bonilha, et al.
Pageof 4